Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.

Br J Cancer · 2014 · PMC4119992 · PMID 25010863

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When IGF-1 treatment was combined with SRPIN340, there was a 54% reduction in the IGF-1 induced nuclear localisation of SRSF1 compared with untreated cells (although this did not reach statistical significance).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.